Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 56 years ago
101 views
Shared 56 years ago
426K views
Shared 56 years ago
46K views
Shared 56 years ago
32K views
Shared 56 years ago
213K views
Shared 56 years ago
117K views
Shared 56 years ago
114K views
Shared 56 years ago
55 views
Shared 56 years ago
167 views
Shared 56 years ago
91 views
Shared 56 years ago
102 views
Shared 56 years ago
246 views
Shared 56 years ago
189 views
Shared 56 years ago
283 views
